Pyrethroids Survey in China

Report edition: 2011 edition(1)
Finished time: Jul. 2011
Document type: PDF
Total pages : 191
Language version: English
Published by CCM

Single user license: -85% $ 1,200.00
List Price $ 8,000.00

Corporate license: -85% $ 3,000.00
List Price $ 20,000.00

All the prices on this website exclude VAT.

Introduction
Main contents
List of tables
List of figures

Description:

Pyrethroids, a category of broad-spectrum, high-efficiency and low-toxicity insecticide, have witnessed a fast development in the past few years in China, and they have been playing an increasingly important role in the pest control on various crops in China, ranking the third place both by domestic consumption volume and market value in all the categories of insecticides in 2010. In China, there have been more than 50 pyrethroids produced and promoted as of the end of May 2011. Pyrethroids can offer substantial benefits to the modern agriculture, especially in the major emerging markets, the demand for low-cost solutions will remain strong. Smartly mixed with new compounds and combined different modes of action, pyrethroids are very well suited for future pest control.

Pyrethroids Survey in China is CCM’s first edition report on Chinese pyrethroids industry, finished in July 2011. This intelligence report attaches importance to the following parts:

  Update all the data related to pyrethroids industry from technical and formulations in China in the past years, including registration, supply, export, price, demand, etc.

  Identify the leading players and emerging products of pyrethroids industry in China.

  Emphasize on demand volume and value of pyrethroids market in 2008-2010, as well as the consumption structure by crops.

  Figure out the development status and influencing factors including drivers and barriers.

  Forecast on pyrethroids from supply, export, price, demand volume and value in 2011-2015.

  Get a clear understanding of the future development trend, and identify China’s position of pyrethroids industry from a global perspective.

  Explore commercial opportunities of pyrethroids industry in China under the context of the new global economy situation.

  SWOT analysis of top 5 domestic pyrethroids players

Twelve major pyrethroids studied in this report:

Lambda-cyhalothrin

Bifenthrin

  Alpha-cypermethrin

  Beta-cyfluthrin

  Beta-cypermethrin

  Deltamethrin

Cypermethrin

Fenpropathrin

Fenvalerate

Esfenvalerate

Cyfluthrin

Permethrin

Main contents:

(The price of report chapters below is for single user license, please contact us if you want to update to corporate license.)

No.	Content	Page	Price
5	Executive summary	1	$ 400
6	Introduction & methodology	3	$ 320
7	Overview of pyrethroids industry in China	7	$ 720
7-1	Definition and classification of pyrethroids	7	$ 160
7-2	Development history of pyrethroids industry in China	8	$ 160
7-3	Position of pyrethroids in the global insecticide industry	9	$ 160
7-4	Position of pyrethroids in Chinese insecticide industry	11	$ 160
7-5	Comprehensive economic benefit analysis (Industry scale, profit level)	12	$ 160
8	Supply and demand of pyrethroids in China	14	$ 5,200
8-1	Summary of supply and demand	14	$ 2,000
8-1-1	Supply summary	14	$ 1,040
8-1-1-1	- Production situation (capacity and output), 2008~2010	14	$ 240
8-1-1-2	- Key manufacturers	15	$ 320
8-1-1-3	- Output volume and value of key producers	16	$ 320
8-1-1-4	- SWOT analysis of top 5 manufacturers	16	$ 240
8-1-2	Demand summary	19	$ 1,040
8-1-2-1	Consumption volume and value	19	$ 480
8-1-2-2	Consumption structure	20	$ 400
8-1-2-2-1	- Market share by application fields, 2010
8-1-2-2-2	- Market share by crops, 2010
8-1-2-2-3	- Market share by products, 2010
8-1-2-2-4	- Market share by regions, 2010
8-1-2-3	Consumption habit	27	$ 240
8-2	Supply and demand of key products	28	$ 3,600
8-2-1	Lambda-cyhalothrin	28	$ 480
8-2-1-1	- Registration	28	$ 80
8-2-1-2	- Production situation (capacity, output, key producers, etc.)	31	$ 160
8-2-1-3	- Price	35	$ 160
8-2-1-4	- Consumption (market volume and value, consumption structure, share of key players, etc.)	37	$ 160
8-2-2	Bifenthrin	43	$ 480
8-2-2-1	- Registration	43	$ 80
8-2-2-2	- Production situation (capacity, output, key producers, etc.)	46	$ 160
8-2-2-3	- Price	49	$ 160
8-2-2-4	- Consumption (market volume and value, consumption structure, share of key players, etc.)	51	$ 160
8-2-3	Alpha-cypermethrin	58	$ 480
8-2-3-1	- Registration	58	$ 80
8-2-3-2	- Production situation (capacity, output, key producers, etc.)	60	$ 160
8-2-3-3	- Price	62	$ 160
8-2-3-4	- Consumption (market volume and value, consumption structure, share of key players, etc.)	63	$ 160
8-2-4	Beta-cyfluthrin	65	$ 400
8-2-4-1	- Registration	65	$ 80
8-2-4-2	- Production situation (capacity, output, key producers, etc.)	67	$ 160
8-2-4-3	- Price	68	$ 80
8-2-4-4	- Consumption (market volume and value, consumption structure, share of key players, etc.)	69	$ 160
8-2-5	Deltamethrin	71	$ 400
8-2-5-1	- Registration	71	$ 80
8-2-5-2	- Production situation (capacity, output, key producers, etc.)	72	$ 160
8-2-5-3	- Price	74	$ 80
8-2-5-4	- Consumption (market volume and value, consumption structure, share of key players, etc.)	75	$ 160
8-2-6	Cypermethrin	76	$ 400
8-2-6-1	- Registration	76	$ 80
8-2-6-2	- Production situation (capacity, output, key producers, etc.)	78	$ 160
8-2-6-3	- Price	80	$ 80
8-2-6-4	- Consumption (market volume and value, consumption structure, share of key players, etc.)	81	$ 160
8-2-7	Fenpropathrin	87	$ 400
8-2-7-1	- Registration	87	$ 80
8-2-7-2	- Production situation (capacity, output, key producers, etc.)	88	$ 160
8-2-7-3	- Price	89	$ 80
8-2-7-4	- Consumption (market volume and value, consumption structure, share of key players, etc.)	90	$ 160
8-2-8	Fenvalerate	92	$ 400
8-2-8-1	- Registration	92	$ 80
8-2-8-2	- Production situation (capacity, output, key producers, etc.)	93	$ 160
8-2-8-3	- Price	97	$ 80
8-2-8-4	- Consumption (market volume and value, consumption structure, share of key players, etc.)	95	$ 160
8-2-9	Esfenvalerate	101	$ 400
8-2-9-1	- Registration	101	$ 80
8-2-9-2	- Production situation (capacity, output, key producers, etc.)	102	$ 160
8-2-9-3	- Price	103	$ 80
8-2-9-4	- Consumption (market volume and value, consumption structure, share of key players, etc.)	105	$ 160
8-2-10	Cyfluthrin	107	$ 400
8-2-10-1	- Registration	107	$ 80
8-2-10-2	- Production situation (capacity, output, key producers, etc.)	108	$ 160
8-2-10-3	- Price	109	$ 80
8-2-10-4	- Consumption (market volume and value, consumption structure, share of key players, etc.)	110	$ 160
8-2-11	Permethrin	111	$ 400
8-2-11-1	- Registration	111	$ 80
8-2-11-2	- Production situation (capacity, output, key producers, etc.)	113	$ 160
8-2-11-3	- Price	115	$ 80
8-2-11-4	- Consumption (market volume and value, consumption structure, share of key players, etc.)	117	$ 160
8-2-12	Beta-cypermethrin	123	$ 400
8-2-12-1	- Registration	123	$ 80
8-2-12-2	- Production situation (capacity, output, key producers, etc.)	126	$ 160
8-2-12-3	- Price	128	$ 160
8-2-12-4	- Consumption (market volume and value, consumption structure, share of key players, etc.)	130	$ 160
8-2-13	Others (including potential ones, especially non-crop pyrethroids)	137	$ 320
9	Key factors influencing development of pyrethroids	145	$ 720
9-1	Macro-economic environment ( GDP, peasants’ income level, industry scale, etc.)	145	$ 240
9-1-1	- GDP and per-capital GDP	145	$ 80
9-1-2	- Peasants' income level	147	$ 80
9-1-3	- Industry scale	148	$ 160
9-2	Governmental policies	149	$ 160
9-3	Industry competition	155	$ 160
9-3-1	- Industry concentration	155	$ 160
9-3-2	- Industry competitiveness (Porter's 5 Forces)	156	$ 80
9-4	Distribution channels	157	$ 80
9-5	Supply of raw material and intermediate	158	$ 80
9-6	Production technlology	161	$ 80
10	Forecast, 2011-2015	163	$ 320
10-1	Supply forecast (capacity and output)	163	$ 160
10-2	Demand forecast (market volume and value,consumption structure,etc.)	164	$ 240
11	Risk assessment and market opportunities	165	$ 240
12	Appendix: Profiles of major producers	168	$ 240

successfully!

CheckOut

List of tables:

Table No.	Table Title
Table 3.1-1	Classification of pyrethroids by chemical structure
Table 3.1-2	Classification of pyrethroids by photosensitivity
Table 3.4-1	Classification and major products of insecticide in China, 2011
Table 4.1.1.1-1	Production situation of key pyrethroids in China, as of May 2011, capacity: t/a, output: tonne
Table 4.1.1.2-1	China's top 9 pyrethroid producers and main products, 2010
Table 4.1.1.2-2	Production situation of China's top 9 pyrethroid producers, as of May 2011, capacity: t/a, output: tonne
Table 4.1.1.3-1	Output volume and value of key pyrethroid producers in China, 2008-2010
Table 4.1.1.4-1	SWOT analysis of Nanjing Redsun Group Co., Ltd., 2011
Table 4.1.1.4-2	SWOT analysis of Jiangsu Yangnong Chemical Group Co., Ltd., 2011
Table 4.1.1.4-3	SWOT analysis of Jiangsu Huangma Agrochemicals Co., Ltd., 2011
Table 4.1.1.4-4	SWOT analysis of Shandong Dacheng Pesticide Co., Ltd., 2011
Table 4.1.1.4-5	SWOT analysis of Changzhou Kangmei Chemical Co., Ltd., 2011
Table 4.1.2.1-1	Consumption situation of pyrethroids calculated by AI in China, volume(tonne) and share, 2008-2010
Table 4.1.2.2.3-1	Market volume and value of pyrethroids by products in China, 2008-2010, tonne, '000 USD
Table 4.2.1.1-1	Regional distribution of lambda-cyhalothrin technical registrations in China, by May 2011
Table 4.2.1.1-2	Registration situation of single formulations of lambda-cyhalothrin in China, by May 2011
Table 4.2.1.1-3	Registration situation of mixed formulations of lambda-cyhalothrin in China, by May 2011
Table 4.2.1.2-1	Basic information of lambda-cyhalothrin technical producers in China, as of May 2011
Table 4.2.1.2-2	Capacity and output of lambda-cyhalothrin technical producers in China, as of May 2011
Table 4.2.1.2-3	Capacity situation of active producers of lambda-cyhalothrin technical in China, t/a, as of May 2011
Table 4.2.1.4-1	Apparent consumption of lambda-cyhalothrin in China, converted to 100% AI, tonne, 2008-2010
Table 4.2.1.4-2	Export destination of China's lambda-cyhalothrin, 2010, Kg
Table 4.2.1.4-3	Exporters of lambda-cyhalothrin in China, 2010, Kg
Table 4.2.1.4-4	Market volume and value, consumption structure by formulation types in China, 2008-2010
Table 4.2.2.1-1	Regional distribution of bifenthrin technical registrations in China, by May 2011
Table 4.2.2.1-2	Registration situation of single formulations of bifenthrin in China, by May 2011
Table 4.2.2.1-3	Registration situation of mixed formulations of bifenthrin in China, by May 2011
Table 4.2.2.2-1	Basic information of bifenthrin technical producers in China, as of May 2011
Table 4.2.2.2-2	Capacity and output of bifenthrin technical producers in China, as of May 2011
Table 4.2.2.4-1	Apparent consumption of bifenthrin in China, converted to 100% AI, tonne, 2008-2010
Table 4.2.2.4-2	Export situation of bifenthrin in China, 2010, tonne
Table 4.2.2.4-3	Export volume of bifenthrin in China, 2010, Kg
Table 4.2.2.4-4	Domestic exporter of bifenthrin, 2010, Kg
Table 4.2.2.4-5	Market volume and value of bifenthrin by formulation types in China, 2008-2010
Table 4.2.3.1-1	Regional distribution of alpha-cypermethrin technical registrations in China, by May 2011
Table 4.2.3.1-2	Registration situation of single formulations of alpha-cypermethrin in China, by May 2011
Table 4.2.3.2-1	Basic information of alpha-cypermethrin technical producers in China, as of May 2011
Table 4.2.3.4-1	Apparent consumption of alpha-cypermethrin calculated by 100% AI in China, tonne, 2008-2010
Table 4.2.3.4-2	Market volume and value of alpha-cypermethrin by formulation types in China, 2008-2010
Table 4.2.4.1-1	Regional distribution of beta-cyfluthrin technical registrations in China, by May 2011
Table 4.2.4.1-2	Registration situation of single formulations of beta-cyfluthrin in China, by May 2011
Table 4.2.4.2-1	Basic information of beta-cyfluthrin technical producers in China, as of May 2011
Table 4.2.4.2-2	Capacity and output of beta-cyfluthrin technical producers in China, as of May 2011
Table 4.2.4.4-1	Apparent consumption of beta-cyfluthrin by 100% AI in China, tonne, 2008-2010
Table 4.2.4.4-2	Market volume and value of beta-cyfluthrin formulations in China, 2008-2010
Table 4.2.5.1-1	Regional distribution of deltamethrin technical registered in China, by May 2011
Table 4.2.5.2-1	Basic information of deltamethrin technical producers in China, as of May 2011
Table 4.2.5.2-2	Capacity and output of technical producers in China, as of May 2011, Capacity: t/a, Output: t
Table 4.2.5.4-1	Apparent consumption of deltamethrin in China, converted to 100% AI, tonne, 2008-2010
Table 4.2.5.4-2	Market volume and value of deltamethrin by formulations in China, 2008-2010
Table 4.2.6.1-1	Regional distribution of cypermethrin technical registrations in China, by May 2011
Table 4.2.6.1-2	Registration situation of single formulations of cypermethrin in China, by May 2011
Table 4.2.6.2-1	Basic information of cypermethrin technical producers in China, as of May 2011
Table 4.2.6.2-2	Capacity and output of cypermethrin technical producers in China, as of May 2011, Capacity: t/a, Output: t
Table 4.2.6.4-1	Apparent consumption of cypermethrin in China, converted to 100% AI, tonne, 2008-2010
Table 4.2.6.4-2	Monthly export situation of cypermethrin in China, 2010
Table 4.2.6.4-3	Monthly export situation of cypermethrin in China, 2009
Table 4.2.6.4-4	Export destination of China's cypermethrin, 2010, Kg
Table 4.2.6.4-5	Export destination of China's cypermethrin, 2009, Kg
Table 4.2.6.4-6	Exporters of cypermethrin in China, 2010, Kg
Table 4.2.6.4-7	Exporters of cypermethrin in China, 2009, Kg
Table 4.2.6.4-8	Market volume and value of cypermethrin by formulation types in China, 2008-2010
Table 4.2.7.1-1	Regional distribution of fenpropathrin technical registrations in China, by May 2011
Table 4.2.7.1-2	Registration situation of single formulations of fenpropathrin in China, by May 2011
Table 4.2.7.2-1	Basic information of fenpropathrin technical producers in China, as of May 2011
Table 4.2.7.2-2	Capacity and output of fenpropathrin technical producers in China, as of May 2011, Capacity: t/a, Output: t
Table 4.2.7.4-1	Apparent consumption of fenpropathrin in China, converted to 100% AI, tonne, 2008-2010
Table 4.2.7.4-2	Market volume and value of fenpropathrin by formulation types in China, 2008-2010
Table 4.2.8.1-1	Regional distribution of fenvalerate technical registrations in China, by May 2011
Table 4.2.8.1-2	Registration situation of single formulations of fenvalerate in China, by May 2011
Table 4.2.8.2-1	Basic information of fenvalerate technical producers in China, as of May 2011
Table 4.2.8.2-2	Capacity and output of fenvalerate technical producers in China, as of May 2011, Capacity: t/a, Output: t
Table 4.2.8.3-1	Ex-work price of fenvalerate in China, 2007- May 2011
Table 4.2.8.4-1	Apparent consumption of fenvalerate in China, converted to 100% AI, tonne, 2008-2010
Table 4.2.8.4-2	Monthly export situation of fenvalerate in China, 2010
Table 4.2.8.4-3	Monthly export situation of fenvalerate in China, 2009
Table 4.2.8.4-4	Export destination of fenvalerate in China, 2010, Kg
Table 4.2.8.4-5	Export destination of fenvalerate in China, 2009, Kg
Table 4.2.8.4-6	Exporter of fenvalerate in China, 2010, Kg
Table 4.2.8.4-7	Exporter of fenvalerate in China, 2009, Kg
Table 4.2.8.4-8	Market volume and value of fenvalerate formulations in China, 2008-2010
Table 4.2.9.1-1	Regional distribution of esfenvalerate technical registrations in China, by May 2011
Table 4.2.9.1-2	Registration situation of single formulations of esfenvalerate in China, by May 2011
Table 4.2.9.2-1	Basic information of esfenvalerate technical producers in China, as of May 2011
Table 4.2.9.2-2	Capacity and output of esfenvalerate technical producers in China, as of May 2011, Capacity: t/a, Output: t
Table 4.2.9.4-1	Apparent consumption of esfenvalerate in China, converted to 100% AI, tonne, 2008-2010
Table 4.2.9.4-2	Market volume and value of esfenvalerate by formulation types in China, 2008-2010
Table 4.2.10.1-1	Regional distribution of cyfluthrin technical registrations in China, by May 2011
Table 4.2.10.1-2	Registration situation of single formulations of cyfluthrin in China, by May 2011
Table 4.2.10.2-1	Basic information of cyfluthrin technical producers in China, as of May 2011
Table 4.2.10.2-2	Capacity and output of cyfluthrin technical producers in China, as of May 2011, Capacity: t/a, Output: t
Table 4.2.10.4-1	Apparent consumption of cyfluthrin in China, converted to 100% AI, tonne, 2008-2010
Table 4.2.10.4-2	Market volume and value of cyfluthrin by formulation types in China, 2008-2010
Table 4.2.11.1-1	Regional distribution of permethrin technical registrations in China, by May 2011
Table 4.2.11.1-2	Registration situation of single formulations of permethrin in China, by May 2011
Table 4.2.11.2-1	Basic information of permethrin technical producers in China, as of May 2011
Table 4.2.11.2-2	Capacity and output of permethrin technical producers in China, as of May 2011, Capacity: t/a, Output: t
Table 4.2.11.4-1	Apparent consumption of permethrin in China, converted to 100% AI, tonne, 2008-2010
Table 4.2.11.4-2	Monthly export situation of permethrin in China, 2010
Table 4.2.11.4-3	Monthly export situation of permethrin in China, 2009
Table 4.2.11.4-4	Export destination of China's cypermethrin, 2010, Kg
Table 4.2.11.4-5	Export destination of China's permethrin, 2009, Kg
Table 4.2.11.4-6	Exporter of permethrin in China, 2010, Kg
Table 4.2.11.4-7	Exporter of permethrin in China, 2009, Kg
Table 4.2.11.4-8	Market volume and value of permethrin by formulation types in China, 2008-2010
Table 4.2.12.1-1	Regional distribution of beta-cypermethrin technical registrations in China, by May 2011
Table 4.2.12.1-2	Registration situation of single formulations of beta-cypermethrin in China, by May 2011
Table 4.2.12.1-3	Registration situation of mixed formulations of beta-cypermethrin in China, by May 2011
Table 4.2.12.2-1	Basic information of beta-cypermethrin technical producers in China, as of May 2011
Table 4.2.12.2-2	Capacity and output of beta-cypermethrin technical producers in China, as of May 2011
Table 4.2.12.4-1	Apparent consumption of beta-cypermethrin in China, converted to 100% AI, tonne, 2008-2010
Table 4.2.12.4-2	Monthly export situation of beta-cypermethrin in China, 2010
Table 4.2.12.4-3	Monthly export situation of beta-cypermethrin in China, 2009
Table 4.2.12.4-4	Export destination of beta-cypermethrin in China, 2010, Kg
Table 4.2.12.4-5	Export destination of beta-cypermethrin in China, 2009, Kg
Table 4.2.12.4-6	Exporter of beta-cypermethrin in China, 2010, Kg
Table 4.2.12.4-7	Exporter of beta-cypermethrin in China, 2009, Kg
Table 4.2.12.4-8	Market volume and value of beta-cypermethrin formulations in China, 2008-2010
Table 4.2.13-1	Active tetramethrin technical producers in China, 2010-2011
Table 4.2.13-2	Apparent consumption of tetramethrin by active ingredient in China, 2010
Table 4.2.13-3	Active prallethrin technical producers in China, 2010-2011
Table 4.2.13-4	Apparent consumption of prallethrin by active ingredient in China, 2010
Table 4.2.13-5	Active rich-d-t-prallethrin technical producers in China, 2010-2011
Table 4.2.13-6	Apparent consumption of rich-d-t-prallethrin by active ingredient in China, 2010
Table 5.1.2-1	China's policies for boosting peasants' income, 2011
Table 5.2-1	Major administrations and policies on pesticides or pesticide industry in China, 2011
Table 5.2-2	Admittance threshold raised according to the Notice No.285 [2008] by the National Development and Reform Commission
Table 5.2-3	Environmental protection policies and environmental cost in pesticide industry in China, as of May 2011
Table 5.6-1	Technologies to be greatly promoted in China, 2011-2015
Table 6.2-1	Forecast on pyrethroids demand by crops in China, 2011-2015, tonne
Table 8-1	Production situation of major pyrethroids in Jiangsu Yangnong Chemical Group Co., Ltd., 2010-2011
... ...	...
Table 8-9	Production situation of major pyrethroids in Guangdong Linong Enterprise Co., Ltd., 2010-2011

List of figures:

Figure No.	Figure Title
Figure 3.3-1	Global insecticide market by market value, 2010
Figure 3.3-2	Global pyrethroid market by crops, 2010
Figure 3.3-3	Global pyrethroid market by pests, 2010
Figure 3.3-4	Global pyrethroid market by regions, 2010
Figure 3.3-5	Advantages of pyrethroids
Figure 3.4-1	Demand structure of different kinds of insecticides by volume in China, 2010
Figure 4.1.1.1-1	Production situation of pyrethroids in China, 2008-2010
Figure 4.1.2.1-1	Consumption of pyrethroids by AI in China, by volume & value, 2008-2010
Figure 4.1.2.2.1-1	Consumption volume of pyrethroids by application fields in China, 2008-2010
Figure 4.1.2.2.1-2	Market share of pyrethroids by application fields in China, 2010
Figure 4.1.2.2.2-1	Consumption structure of pyrethroids by crops in China, calculated by AI, 2010
Figure 4.1.2.2.2-2	Consumption situation by pyrethroids on cotton in China, 2010
Figure 4.1.2.2.2-3	Consumption situation by pyrethroids on fruits in China, 2010
Figure 4.1.2.2.2-4	Consumption situation by pyrethroids on tea in China, 2010
Figure 4.1.2.2.2-5	Consumption situation by pyrethroids on wheat in China, 2010
Figure 4.1.2.2.2-6	Consumption situation by pyrethroids on vegetable & melons in China, 2010
Figure 4.1.2.2.3-1	Market share of pyrethroids by volume in China, 2010
Figure 4.1.2.2.3-2	Market share of pyrethroids by value in China, 2010
Figure 4.1.2.2.4-1	Domestic pyrethroids consumption structure in agriculture by region, 2010
Figure 4.2.1.1-1	Structure (quantity and share) of lambda-cyhalothrin registrations by formulations types in China, as of May 2011
Figure 4.2.1.2-1	Forecast on lambda-cyhalothrin output, converted to 100% AI, 2011-2015
Figure 4.2.1.3-1	Ex-work prices of lambda-cyhalothrin in China, 2007-May 2011
Figure 4.2.1.3-2	Forecast on price of lambda-cyhalothrin 95% technical in China, 2011-2015
Figure 4.2.1.4-1	Monthly export situation of lambda-cyhalothrin technical in China, 2010
Figure 4.2.1.4-2	Forecast on export volume of lambda-cyhalothrin in China, converted to 100% AI, 2011-2015
Figure 4.2.1.4-3	Domestic consumption structure of lambda-cyhalothrin, volume(t) and share, converted to 100% AI, 2010
Figure 4.2.1.4-4	Forecast on domestic consumption of lambda-cyhalothrin, converted to 100%, 2011-2015
Figure 4.2.2.1-1	Structure of bifenthrin registrations by formulation types in China (quantity and share), by May 2011
Figure 4.2.2.2-1	Capacity and output of bifenthrin technical producers in China, as of May 2011
Figure 4.2.2.2-2	Forecast on output of bifenthrin in China, converted to 100% AI, 2011-2015
Figure 4.2.2.3-1	Ex-work price of bifenthrin in China, 2007-May 2011
Figure 4.2.2.3-2	Forecast on price of bifenthrin technical in China, 2011-2015
Figure 4.2.2.4-1	Monthly export situation of bifenthrin in China, 2010
Figure 4.2.2.4-2	Forecast on export volume of bifenthrin in China, converted to 100% AI, 2011-2015
Figure 4.2.2.4-3	Domestic consumption structure of bifenthrin, volume(t) and share, converted to 100% AI, 2010
Figure 4.2.2.4-4	Forecast on domestic consumption of bifenthrin, converted to 100% AI, 2011-2015
Figure 4.2.3.1-1	Structure of alpha-cypermethrin registrations by formulation types in China, quantity and share, by May 2011
Figure 4.2.3.2-1	Capacity and output of alpha-cypermethrin technical producers in China, as of May 2011
Figure 4.2.3.2-2	Forecast on output of alpha-cypermethrin technical in China, 2011-2015
Figure 4.2.3.3-1	Ex-work price of alpha-cypermethrin in China, 2007-May 2011
Figure 4.2.3.3-2	Forecast on ex-work price of alpha-cypermethrin technical in China, 2011-2015
Figure 4.2.3.4-1	Domestic consumption structure of alpha-cypermethrin by 100% AI, volume (t) and share, 2010
Figure 4.2.3.4-2	Forecast on domestic consumption of alpha-cypermethrin (converted to 100% AI), 2011-2015
Figure 4.2.4.1-1	Structure of beta-cyfluthrin registrations by formulation types in China, quantity and share, by May 2011
Figure 4.2.4.2-1	Forecast on output of beta-cyfluthrin technical in China, 2011-2015
Figure 4.2.4.3-1	Ex-work price of beta-cyfluthrin in China, 2007-May 2011
Figure 4.2.4.3-2	Forecast on ex-work price of beta-cyfluthrin technical in China, 2011-2015
Figure 4.2.4.4-1	Domestic consumption structure of beta-cyfluthrin converted to 100% AI, volume(t) and share, 2010
Figure 4.2.4.4-2	Forecast on consumption of beta-cyfluthrin in China, converted to 100% AI, 2011-2015
Figure 4.2.5.1-1	Structure of deltamethrin registrations by formulation types in China, by May 2011
Figure 4.2.5.1-2	Registration situation of single formulations of deltamethrin in China, by May 2011
Figure 4.2.5.2-1	Forecast on deltamethrin production in China, converted to 100% AI, 2011-2015
Figure 4.2.5.3-1	Ex-work price of deltamethrin TC in China, 2007- May 2011
Figure 4.2.5.3-2	Forecast on price of deltamethrin 95% TC in China, 2011-2015
Figure 4.2.5.4-1	Domestic consumption structure of deltamethrin, converted to 100% AI, 2010
Figure 4.2.5.4-2	Forecast on domestic consumption of deltamethrin, converted to 100% AI, 2011-2015
Figure 4.2.6.1-1	Structure of cypermethrin registrations by formulation types in China, by May 2011
Figure 4.2.6.2-1	Forecast on output of cypermethrin technical in China, 2011-2015
Figure 4.2.6.3-1	Ex-work price of cypermethrin 95% TC in China, 2007- May 2011
Figure 4.2.6.3-2	Forecast on price of cypermethrin 95% technical in China, 2011-2015
Figure 4.2.6.4-1	Forecast on export volume of cypermethrin in China, converted to 100% AI, 2011-2015
Figure 4.2.6.4-2	Domestic consumption structure of cypermethrin, volume(t) and share, converted to 100% AI, 2010
Figure 4.2.6.4-3	Forecast on domestic consumption of cypermethrin, converted to 100% AI, 2011-2015
Figure 4.2.7.1-1	Structure of fenpropathrin registrations by formulation types in China, by May 2011
Figure 4.2.7.2-1	Forecast on output of fenpropathrin in China, converted to 100% AI, 2011-2015
Figure 4.2.7.3-1	Ex-work price of fenpropathrin in China, 2007- May 2011
Figure 4.2.7.3-2	Forecast on price of fenpropathrin 92% technical in China, 2011-2015
Figure 4.2.7.4-1	Domestic consumption structure of fenpropathrin, volume(t) and share, converted to AI 100%, 2010
Figure 4.2.7.4-2	Forecast on domestic consumption of fenpropathrin, converted to 100% AI, 2011-2015
Figure 4.2.8.1-1	Structure of fenvalerate registrations by formulation types in China, by May 2011
Figure 4.2.8.2-1	Forecast on output of fenvalerate in China, converted to 100% AI, 2011-2015
Figure 4.2.8.3-1	Forecast on price of fenvalerate 92% technical in China, 2011-2015
Figure 4.2.8.4-1	Domestic consumption structure of fenvalerate,volume(t) and share, converted to AI 100%, 2010
Figure 4.2.8.4-2	Forecast on domestic consumption of fenvalerate, converted to 100% AI, 2011-2015
Figure 4.2.9.1-1	Structure of esfenvalerate registrations by formulation types in China, by May 2011
Figure 4.2.9.2-1	Forecast of output of esfenvalerate technical in China, 2011-2015
Figure 4.2.9.3-1	Ex-work price of esfenvalerate in China, 2007-May 2011
Figure 4.2.9.3-2	Forecast on price of 95% esfenvalerate technical in China, 2011-2015
Figure 4.2.9.4-1	Domestic consumption structure of esfenvalerate, converted to 100%, volume(t) and share, 2010
Figure 4.2.9.4-2	Forecast on domestic consumption of esfenvalerate, converted to 100% AI, 2011-2015
Figure 4.2.10.1-1	Structure of cyfluthrin registrations by formulation types in China, by May 2011
Figure 4.2.10.3-1	Ex-work price of cyfluthrin in China, 2007- May 2011
Figure 4.2.10.3-2	Forecast on price of cyfluthrin 92% technical in China, 2011-2015
Figure 4.2.10.4-1	Domestic consumption structure of cyfluthrin, volume(t) and share, converted to 100% AI, 2010
Figure 4.2.10.4-2	Forecast on domestic consumption of cyfluthrin, converted to 100% AI, 2011-2015
Figure 4.2.11.1-1	Structure of permethrin registrations by formulation types in China, by May 2011
Figure 4.2.11.2-1	Forecast on output of 95% permethrin technical in China, 2011-2015
Figure 4.2.11.3-1	Ex-work price of 95% permethrin technical in China, 2007- May 2011
Figure 4.2.11.3-2	Forecast on price of permethrin 95% technical in China, 2011-2015
Figure 4.2.11.4-1	Domestic consumption structure of permethrin, volume(t) and share, 2010
Figure 4.2.11.4-2	Forecast on domestic consumption of permethrin, converted to 100% AI, 2011-2015
Figure 4.2.12.1-1	Structure (quantity and share) of beta-cypermethrin registrations by formulation types in China, by May 2011
Figure 4.2.12.2-1	Forecast on output of beta-cypermethrin technical in China, 2011-2015
Figure 4.2.12.3-1	Ex-work price of beta-cypermethrin in China, 2007-May 2011
Figure 4.2.12.3-2	Forecast on ex-work price of 95% beta-cypermethrin technical in China, 2011-2015
Figure 4.2.12.4-1	Forecast on export volume of beta-cypermethrin in China, converted to 100% AI, 2011-2015
Figure 4.2.12.4-2	Domestic consumption structure of beta-cypermethrin (volume(t) and share), converted to 100%, 2010
Figure 4.2.12.4-3	Forecast on domestic consumption of beta-cypermethrin, converted to 100% AI, 2011-2015
Figure 5.1.1-1	China's GDP growth, 2001-2010
Figure 5.1.2-1	Income change of Chinese peasants, 2004-2010
Figure 5.3.2-1	Evaluation of Porter's 5 Forces of Chinese pyrethroid industry, 2011
Figure 5.4-1	Distribution channel of pyrethroids in China, 2010
Figure 5.5-1	Output and sales volume of 3,3-diMethyl-4-pentenoic acid methylester in China, 2003-2010
Figure 5.5-2	Ex-work price of thionyl chloride in China, 2007-May 2011
Figure 5.5-3	Consumption structrue of thionyl chloride by volume in China, 2010
Figure 6.1-1	Forecast on capacity and output of pyrethroids by AI in China, 2011-2015, tonne
Figure 6.2-1	Forecast on demand volume and value of pyrethroids in China, 2011-2015

CCM Customized Service on Market Research

Do you want Import & Export Analysis, Financial Data, Cost Analysis, Supply Chain Research etc. ? We will customize the specific research for you, in case the services listed above does not meet your precise requirements. Our product and industry research in China’s agriculture, chemicals, food & ingredients and life science markets will comprehensively cover the business information, which is able to help you arrive at strategic and profitable business decisions.

Please directly contact econtact@cnchemicals.com to specify your Market Research Requirement

SAMPLE DOWNLOAD

In order to provide you with access to all the free content on this site, we would like you to tell us who you are.
Please enter the following - you will only have to do this once. Or if you already have an account, please sign in here.

* Name
* Your E-mail address
* Your phone number
Your company
* Your industry

Recommend Report

Need some help to find your information ?

Search Report

Recommend Newsletter

Related market data

Related product

Related research

Pyrethroids Survey in China

Single user license: -85% $ 1,200.00
List Price $ 8,000.00

Corporate license: -85% $ 3,000.00
List Price $ 20,000.00

All the prices on this website exclude VAT.

Description:

Main contents:

List of tables:

List of figures:

CCM Customized Service on Market Research

SAMPLE DOWNLOAD

My Products (0 items)

Login/Register

Recommend Report

Need some help to find your information ?

Search Report

Recommend Newsletter

Related market data

Related product

Related research

Pyrethroids Survey in China

Single user license: -85% $ 1,200.00 List Price $ 8,000.00 Corporate license: -85% $ 3,000.00 List Price $ 20,000.00 All the prices on this website exclude VAT.

Description:

Main contents:

List of tables:

List of figures:

CCM Customized Service on Market Research

SAMPLE DOWNLOAD

Single user license: -85% $ 1,200.00
List Price $ 8,000.00

Corporate license: -85% $ 3,000.00
List Price $ 20,000.00

All the prices on this website exclude VAT.